Document is current
Any future updates will be listed below
-
Authors
Liang, Xue
Arrey, Gerard
Qin, Yating
Álvarez-González, Lucía https://orcid.org/0000-0001-8154-8614
Hariprakash, Judith Mary https://orcid.org/0000-0002-1164-347X
Ma, Jie
Holt, Sylvester https://orcid.org/0000-0002-9958-0169
Han, Peng https://orcid.org/0000-0002-3405-087X
Luo, Yonglun https://orcid.org/0000-0002-0007-7759
Li, Hanbo https://orcid.org/0000-0001-8778-9988
Ruiz-Herrera, Aurora https://orcid.org/0000-0003-3868-6151
Pilegaard, Henriette https://orcid.org/0000-0002-1071-0327
Regenberg, Birgitte https://orcid.org/0000-0003-4996-7012
-
Funding
Funding for this research was provided by:
Novo Nordisk (NNF18OC0053139; NNF21OC0072023)
- License Information
-
More Information
Article History
Received: 21 January 2024
Accepted: 29 January 2025
First Online: 22 February 2025
Competing interests
: B.R. is co-founder of CARE-DNA. X.L., Y.Q., P.H. are funded by Qingdao-Europe Advanced Institute for Life Sciences (QEI). J.M., Y.L., H.L. are or were employed by BGI. G.A., L.A.-G., J.M.H., S.H., A.R.-H., and H.P. declare that they have no known competing interests.
